4D Molecular Therapeutics

Home » 4D Molecular Therapeutics

IPO

4D Molecular Therapeutics

Biotechnology

We are a development stage precision gene therapy company dedicated to pioneering the development of targeted therapies based on our next-generation AAV vectors.

Symbol

DDDD

Price Range
TBD

Anticipated Shares
TBD

Anticipated Date
TBD

Underwriters
GOLDMAN SACHS & CO. LLC

To view the prospectus for 4D Molecular Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253